University of Pennsylvania Hospital

Philadelphia, Pennsylvania 19106

12 studies enrolling now · 63 studies all time

What they study most

Abdominal Aortic Aneurysms, Adult-type Diffuse Gliomas, Alcohol-related Liver Disease, Any Solid Tumor, Aortic Stenosis, Aortic Stenosis, Severe, Arrhythmias, Cardiac, Atopic Dermatitis, Atrial Fibrillation, Autoregulation, B-cell Lymphoma, Bladder Cancer

Studies at this site

• 18F-FTHA IMAGING OF THE INTESTINAL AND CENTRAL LYMPHATIC SYSTEM — Recruiting now
• A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer — Recruiting now
• A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA) — Recruiting now
• Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH) — Recruiting now
• Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass — Recruiting now
• FTT PET/CT in Metastatic Prostate Cancer — Recruiting now
• A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib — Recruiting now
• A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma — Recruiting now
• CoMind Early Feasibility Study — Recruiting now
• CT Evaluation of Carotid Plaque Components — Recruiting now
• PARTNER 3 Trial - Aortic Valve-in-Valve — Recruiting now
• Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss — Completed
• [18F]FES PET/CT in Endocrine Refractory Breast Cancer — Stopped early
• Evaluation of Accelerated Sampling Techniques for Vessel Wall Imaging — Starting soon
• A Study of Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001) — Running, not enrolling
• Citadel Embolization Device Study — Running, not enrolling
• A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer — Running, not enrolling
• Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease — Completed
• Biosynthesis of PGD2 in Vivo — Completed
• A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL — Completed
• [18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer — Running, not enrolling
• Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations — Stopped early
• Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH) — Completed
• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed
• A Study of LY3405105 in Participants With Advanced Cancer — Stopped early
• [18F]FLT PET/CT in Rb+ Metastatic Breast Cancer — Running, not enrolling
• FDG PET/CT in Breast Cancer Bone Mets — Running, not enrolling
• LimiFlex Clinical Trial for the Treatment of Degenerative Spondylolisthesis With Spinal Stenosis — Running, not enrolling
• CanGaroo® Registry Study — Completed
• Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation — APPROVED_FOR_MARKETING
• PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - S3 Intermediate — Completed
• A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer — Completed
• Tipifarnib in Subjects With Chronic Myelomonocytic Leukemia, Other MDS/MPN, and Acute Myeloid Leukemia — Completed
• A Study of Itacitinib for the Prevention of Cytokine Release Syndrome Induced by Immune Effector Cell Therapy — Completed
• PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk — Completed
• A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation — Stopped early
• A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA) — Completed
• Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations — Completed
• Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers — Completed
• Endurant Bifurcated and Aorto-Uni-Iliac (AUI) Stent Graft System — Completed
• VALOR: The Talent Thoracic Stent Graft System Clinical Study — Completed
• Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients — Completed
• [18F]FES PET/CT in PAH — Stopped early
• A Clinical Trial to Evaluate the HeartWare™ Ventricular Assist System (ENDURANCE SUPPLEMENTAL TRIAL) — Completed
• A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL — Completed
• Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH — Stopped early
• The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B — Completed
• The HeartWare™ Ventricular Assist System as Destination Therapy of Advanced Heart Failure: the ENDURANCE Trial — Completed
• Gilead Sustained Virologic Response (SVR) Registry — Completed
• A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors — Completed